[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer

Summary

The purpose of this study is to test the ability of a new PET scan radiotracer, called FDHT (stands for \[18F\] Dihydro-Testosterone), to better find and monitor prostate cancer. Radiotracers are a type of drug that carries small amounts of radioactivity that can be seen by the PET scanner. FDHT is a radiotracer that looks for a protein which is present in almost all prostate cancer cells. The investigators want to find out if we can find and monitor changes in cancer using a FDHT PET scan.

Timeline

Start

2014-11

Primary completion

2018-08

Completion

2018-08

Drugs

Indications